Guerrera Luigi Pio, Suarato Gabriella, Napolitano Rossella, Perrone Alessandra, Caputo Vincenza, Ventriglia Anna, Martini Giulia, Della Corte Carminia Maria, Orditura Michele, Martinelli Erika, Ciardiello Fortunato, Montella Marco, Franco Renato, Troiani Teresa, Napolitano Stefania
Medical Oncology, Department of Precision Medicine, Università degli Studi della Campania "Luigi Vanvitelli", 80131 Napoli, Italy.
Pathology Unit, Department of Mental and Physical Health and Preventive Medicine, Università degli Studi della Campania "Luigi Vanvitelli", 80138 Napoli, Italy.
Healthcare (Basel). 2022 Apr 11;10(4):708. doi: 10.3390/healthcare10040708.
Mixed neuroendocrine non-neuroendocrine neoplasms (MiNENs) refer to heterogenous rare neoplasms constituted of at least a neuroendocrine population-either well-differentiated, or more frequently poorly differentiated-and a non-neuroendocrine population, both accounting for at least 30% of the whole tumor mass. Several studies recently focused on the key genetic and epigenetic changes underlying MiNENs to better understand how they develop, and explore biological similarities among the two components and their pure counterparts. However, their molecular landscape still remains poorly understood. NGS may represent a useful tool to study this orphan disease by detecting the main genetic alterations and possible therapeutic targets. NGS analysis on tissue and/or blood samples through the Foundation One (F1) platform was performed on consecutive samples collected from four patients diagnosed with MiNENs of the gastroenteric tract. Several genetic alterations were shared among samples from the same patients, thus suggesting a common origin between them, although morphology sometimes changed at histopathological evaluation. Common molecular alterations among samples from different patients that had not been previously described to our knowledge were also detected. Finally, it is of the utmost importance to clarify if the maintenance of the 30% cut-off is still essential in defining MiNENs and really manages to include all of the mixed neoplasms.
混合性神经内分泌-非神经内分泌肿瘤(MiNENs)是指由至少一种神经内分泌细胞群(分化良好的,或更常见的分化不良的)和一种非神经内分泌细胞群组成的异质性罕见肿瘤,两者均占整个肿瘤体积的至少30%。最近有几项研究聚焦于MiNENs潜在的关键基因和表观遗传变化,以更好地了解它们的发展过程,并探索这两种成分与其纯合对应物之间的生物学相似性。然而,它们的分子格局仍知之甚少。二代测序(NGS)可能是一种通过检测主要基因改变和潜在治疗靶点来研究这种罕见疾病的有用工具。我们通过Foundation One(F1)平台对连续收集的4例胃肠道MiNENs患者的组织和/或血液样本进行了NGS分析。同一患者的样本之间存在几种共同的基因改变,这表明它们之间有共同的起源,尽管在组织病理学评估中形态有时会发生变化。我们还检测到了不同患者样本之间以前未被报道过的常见分子改变。最后,至关重要的是要弄清楚在定义MiNENs时维持30%的临界值是否仍然必不可少,以及它是否真的能涵盖所有的混合性肿瘤。